Premium
Bioresorbable Scaffolds with Biocatalytic Chemotherapy and In Situ Microenvironment Modulation for Postoperative Tissue Repair
Author(s) -
Xue ChenCheng,
Li MengHuan,
Sutrisno Linawati,
Yan BeiBei,
Zhao Yang,
Hu Yan,
Cai KaiYong,
Zhao Yanli,
Yu ShuHong,
Luo Zhong
Publication year - 2021
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.202008732
Subject(s) - scaffold , materials science , regeneration (biology) , polycaprolactone , electrospinning , hyaluronic acid , gelatin , cancer research , biomedical engineering , nanofiber , medicine , nanotechnology , chemistry , microbiology and biotechnology , biochemistry , polymer , biology , anatomy , composite material
New biomaterials with antitumor and tissue repair function have become increasingly important for the postoperative care of melanoma surgery, which could prolong the tumor‐free survival of patients while simultaneously facilitating the reconstruction of the trauma tissue. For this purpose, a bioresorbable composite scaffold is designed which is fabricated by depositing therapeutic amorphous calcium carbonate (ACC)‐based nanoformulations in gelatin/polycaprolactone (GP) nanofibers via electrospinning. The ACC nanoformulations are integrated with Fe 2+ ‐preactivated bleomycin to deliver biocatalytically enhanced therapeutic effect while the hydrolysable ACC contents can act as proton scavengers to ameliorate the tumor tissue acidity in situ, leading to sustained inhibition on tumor recurrence and metastasis. The acid‐triggered ACC decomposition also releases Ca 2+ to activate the downstream Wnt/β‐catenin signaling pathways, which can cooperate with the healing effect of the GP substrate and accelerate wound regeneration. The nanoengineered scaffold can be useful as a supplementary treatment for the postoperative management of melanoma.